Task: Answer the multiple-choice question.
Query: Which drug exhibits a 21.171% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. COc1cc2ccccc2cc1C(=O)Nc1ccc(Br)cn1
b. CNC(=S)Nc1ccc(C)c(NC(=S)NC)c1
c. Cn1cc([N+](=O)[O-])c(C(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)n1
Answer: a. COc1cc2ccccc2cc1C(=O)Nc1ccc(Br)cn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc2ccccc2cc1C(=O)Nc1ccc(Br)cn1
COc1cc2ccccc2cc1C(=O)Nc1ccc(Br)cn1
N-(5-bromopyridin-2-yl)-3-methoxynaphthalene-2-carboxamide